Food and Supplements Industries Eye New NDIN Guidance from FDA
The Food and Drug Administration has released a Final Guidance for Industry to address some ongoing issues with procedures and timing for submitting… read more
Latest News
ToxStrategies is Presenting and Exhibiting at SOT 2024!
ToxStrategies is excited to be attending, presenting, and exhibiting at the Society of Toxicology’s 63rd Annual Meeting and ToxExpo, March 9th 2024, to… read more
Healthcare resource use by PSVT patients undergoing cardiac ablation
HEORStrategies’ Dr. Naomi Sacks is a co-author on a study of healthcare resource use and costs in cardiac arrhythmia patients with paroxysmal supraventricular… read more
EPA issues a framework for identifying eye irritation or corrosion hazards for new chemicals reviewed under TSCA, prioritizing non-animal methods
On January 8, 2024, EPA issued a new framework for identifying eye irritation or corrosion hazards for new chemicals reviewed under the Toxic… read more
ToxStrategies has exciting news from the FDA Center for Veterinary Medicine!
The Center for Veterinary Medicine (CVM) is paving the way for innovation in the animal feed industry! In a recent Letter to Industry,… read more
Final Rule on reporting and recordkeeping requirements for PFAS
The US Environmental Protection Agency (EPA) has issued a final rule on reporting and recordkeeping requirements for per- and polyfluoroalkyl substances (PFAS) through… read more
ToxStrategies Welcomes Brent Finley, Ph.D., DABT
ToxStrategies is pleased to announce that nationally recognized toxicologist Dr. Brent Finley has joined our firm as an Executive Vice President. Dr. Finley… read more
EpidStrategies Supports Neuralace Medical Submission for FDA Approval of Axon Therapy
Neuralace Medical recently received FDA clearance of Axon Therapy for diabetic patients suffering from chronic painful neuropathy. The EpidStrategies medical device trials team… read more